Nailing Down Internet Based Information on Onychomycosis
JDD August PodcastPodcast host Dr. Adam Friedman sat down with Dr. Shari Lipner, associate professor of dermatology at New York-Presbyterian Hospital/Weill Cornell Medical Center and international nail expert extraordinaire, to discuss the accuracy and quality of internet based information on Onychomycosis.  Dr. Aaron Fong, PGY-3 dermatology resident at George Washington University School of Medicine and Health …
JDD August Podcast
Identifying Gaps in Sun Protection Perceptions and Use in Native Americans
JDD Podcast RecapPodcast host Dr. Adam Friedman sat down with Dr. Vivian Shi, Assistant Professor of Dermatology at University of Arizona, to discuss skin cancer epidemiology and sun protection behavior among Native Americans.  Dr. Vivian Shi’s most recent study published in the June 2019 edition of JDD highlights clear shortcomings in this group. Below are are the podcast highlights. Key Takeaways This …
JDD Podcast Recap
Systemic Therapy Considerations for Psoriasis in the Setting of Malignancy
Psoriasis PodcastJDD Podcast Recap and Author Interview Podcast host Dr. Adam Friedman sat down with Dr. David Rosmarin, Assistant Professor of Dermatology and Residency Program Director at Tufts University School of Medicine, to dive into what he learned from performing a retrospective chart review and how his work and his experience guides his clinical decision making when managing psoriasis. Here are the high …
Psoriasis Podcast
Management of Seborrheic Keratoses with Dr. Adam Friedman
Seborrheic KeratosesA Recap of the JDD October Podcast Seborrheic keratoses (SKs), though harmless, are one of the most common patient concerns.  Their aesthetic impact makes them one of the most common dermatologic complaints, however treatment options are limited.  In this special of the JDD podcast series, Dr. Adam Friedman discusses his group’s article “Managing Seborrheic Keratosis: Evolving Strategies an …
Seborrheic Keratoses
Psoriasis Therapeutics and Marketing
psoriasis therapeuticsJDD Podcast Recap and Author Interview There has been vast growth in the array of treatment options for psoriasis over the last two decades.  Not surprisingly, the variety of new drugs for this chronic condition has resulted in substantial direct-to-consumer marketing.  However, patients with psoriasis are still largely undertreated.  This discrepancy is explored in the paper “Discordance Be …
psoriasis therapeutics
error

Enjoy this blog? Please spread the word :)